Serum TGF-β1 levels in the current study’s T2DM patients were higher than those in healthy individuals who did not have diabetes or cardiac impairment, indicating that TGF-β1 is more active in T2DM patients. Here, TGFB1 is linked to type 2 diabetes mellitus.